# Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate Cancer

> **NCT01558492** · PHASE2 · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 3 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT01558492
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-03
- **Primary completion:** 2012-06
- **Final completion:** 2013-11
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Poor accrual
- **Last updated:** 2017-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01558492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01558492, "Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01558492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*